David Sans
No más puestos en curso
Fortuna: 10 347 $ al 31/03/2024
Perfil
David Sans worked as the Head of Business Development at ImClone LLC and as the Chief Corporate Development at Calidi Biotherapeutics, Inc. He holds a doctorate degree from Ramon Llull University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/09/2023 | 18 314 ( 0.05% ) | 10 347 $ | 31/03/2024 |
Antiguos cargos conocidos de David Sans.
| Empresas | Cargo | Fin |
|---|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Director/Board Member | - |
| CALIDI BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formación de David Sans.
| Ramon Llull University | Doctorate Degree |
Experiencias
Funciones ocupadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CALIDI BIOTHERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- David Sans
